Linda Shurzinske

Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease

Bertram Pitt, David D. Waters, W. Virgil Brown et al. · New England Journal of Medicine · 1999 · 948 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Guillermo E. Umpierrez, Federico Pérez Manghi, Linda Shurzinske et al. · Diabetes Care · 2014 · 337 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate

Teik Chye Ooi, Therèse Heinonen, Petar Alaupovic et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1997 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

Petar Alaupovic, Therèse Heinonen, Linda Shurzinske et al. · Atherosclerosis · 1997 · 54 citations

Life Sciences, Pharmacology, Pharmacotherapy +16

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study

Therèse Heinonen, Evan A. Stein, Stuart Weiss et al. · Clinical Therapeutics · 1996 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +13